Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

This study is currently recruiting participants. (see Contacts and Locations)

Verified January 2015 by Asan Medical Center

Sponsor:

Information provided by (Responsible Party):

Sang-Ho Choi, Asan Medical Center

ClinicalTrials.gov Identifier:

NCT01068990

First received: February 12, 2010

Last updated: January 12, 2015

Last verified: January 2015

History of Changes

Purpose

This study is a prospective observation study for lower respiratory tract infections in medical intensive care unit. Microbiologic and clinical characteristics and outcomes of patients with severe pneumonia in medical intensive care unit will be monitored and analyzed.

Condition
Severe Pneumonia


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

Resource links provided by NLM:

MedlinePlus related topics: Pneumonia

U.S. FDA Resources

Further study details as provided by Asan Medical Center:

Primary Outcome Measures:

Identification of etiology of pneumonia [ Time Frame: 7 day from the time of pneumonia diagnosis ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Pneumonia-related death [ Time Frame: 1 month ] [ Designated as safety issue: No ]


Estimated Enrollment:	300
Study Start Date:	March 2010
Estimated Study Completion Date:	February 2018
Estimated Primary Completion Date:	February 2018 (Final data collection date for primary outcome measure)

Detailed Description:

All patients admitting medical ICU will be monitored for pneumonia. Both community-acquired (including health-care associated pneumonia) and hospital-acquired pneumonia will be included. Collecting data will include patient demographic characteristics, clinical features, microbiological characteristics including molecular work, and outcome.

Eligibility


Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients admitting or admitted in medical ICU with pneumonia

Criteria

Inclusion Criteria:

Patients admitting medical ICU with pneumonia
Medical ICU admitted patients who is developed new pneumonia

Exclusion Criteria:

Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01068990

Contacts


Contact: Sang-Ho Choi, MD	+82-2-3010-3304	sangho@amc.seoul.kr

Locations


Korea, Republic of
Asan Medical Center	Recruiting
Seoul, Korea, Republic of, 138-736
Principal Investigator: Sang-Ho Choi, MD

Sponsors and Collaborators

Asan Medical Center

Investigators


Principal Investigator:	Sang-Ho Choi, MD	Asan Medical Center

More Information

No publications provided


Responsible Party:	Sang-Ho Choi, Doctor, Asan Medical Center
ClinicalTrials.gov Identifier:	NCT01068990 History of Changes
Other Study ID Numbers:	AICUP
Study First Received:	February 12, 2010
Last Updated:	January 12, 2015
Health Authority:	Korea: Institutional Review Board

Keywords provided by Asan Medical Center:


pneumonia

Additional relevant MeSH terms:


Respiratory Tract Infections Infection Respiratory Tract Diseases

ClinicalTrials.gov processed this record on March 01, 2015

To Top